Sylvie Linotte

1.8k total citations · 1 hit paper
25 papers, 1.3k citations indexed

About

Sylvie Linotte is a scholar working on Psychiatry and Mental health, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Sylvie Linotte has authored 25 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Psychiatry and Mental health, 11 papers in Pharmacology and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in Sylvie Linotte's work include Treatment of Major Depression (11 papers), Bipolar Disorder and Treatment (10 papers) and Tryptophan and brain disorders (7 papers). Sylvie Linotte is often cited by papers focused on Treatment of Major Depression (11 papers), Bipolar Disorder and Treatment (10 papers) and Tryptophan and brain disorders (7 papers). Sylvie Linotte collaborates with scholars based in Belgium, Israel and Austria. Sylvie Linotte's co-authors include Bruno Rossion, L. Gauthier, Paul‐André Despland, Marc Crommelinck, Raymond Bruyer, Michael J. Tarr, Julien Mendlewicz, Daniel Souery, Isabelle Massat and Siegfried Kasper and has published in prestigious journals such as PLoS ONE, Journal of Affective Disorders and European Journal of Pharmacology.

In The Last Decade

Sylvie Linotte

25 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The N170 occipito-temporal component is delayed and enhanced to inverted faces but not to inverted objects

2000 612 citations Bruno Rossion, L. Gauthier et al. Neuroreport profile →

Peers

Sylvie Linotte

PMH

ECP

PHARM

Murat Altinay United States

Johanna Scheuerecker Germany

Martina Ballmaier United States

Steven Ziebell United States

Clifford I. Workman United States

Elias Mouchlianitis United Kingdom

Blynn G. Bunney United States

Timm Rosburg Germany

Eiji Kirino Japan

Jieun Kim United States

Murat Altinay United States

Sylvie Linotte

297 ×0.4

247 ×0.8

PMH

116 ×0.4

ECP

95 ×0.3

PHARM

100 ×0.5

Citations per year, relative to Sylvie Linotte Sylvie Linotte (= 1×) peers Murat Altinay

Countries citing papers authored by Sylvie Linotte

Since Specialization

Citations

This map shows the geographic impact of Sylvie Linotte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvie Linotte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvie Linotte more than expected).

Fields of papers citing papers by Sylvie Linotte

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvie Linotte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvie Linotte. The network helps show where Sylvie Linotte may publish in the future.

Co-authorship network of co-authors of Sylvie Linotte

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvie Linotte. A scholar is included among the top collaborators of Sylvie Linotte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvie Linotte. Sylvie Linotte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schosser, Alexandra, Laura Carlberg, Raffaella Calati, et al.. (2017). The Impact of BDNF Polymorphisms on Suicidality in Treatment-Resistant Major Depressive Disorder: A European Multicenter Study. The International Journal of Neuropsychopharmacology. 20(10). 782–787. 10 indexed citations

Höfer, Peter, Alexandra Schosser, Raffaella Calati, et al.. (2012). The impact of Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes on suicide attempt and suicide risk—a European multicentre study on treatment-resistant major depressive disorder. European Archives of Psychiatry and Clinical Neuroscience. 263(5). 385–391. 13 indexed citations

Massat, Isabelle, Hichem Slama, Martin Kavec, et al.. (2012). Working Memory-Related Functional Brain Patterns in Never Medicated Children with ADHD. PLoS ONE. 7(11). e49392–e49392. 61 indexed citations

Mendlewicz, Julien, Concetta Crisafulli, Raffaella Calati, et al.. (2012). Influence of COX-2 and OXTR polymorphisms on treatment outcome in treatment resistant depression. Neuroscience Letters. 516(1). 85–88. 18 indexed citations

Serretti, Alessandro, Alberto Chiesa, Concetta Crisafulli, et al.. (2012). Failure to Replicate Influence of GRIK4 and GNB3 Polymorphisms on Treatment Outcome in Major Depression. Neuropsychobiology. 65(2). 70–75. 21 indexed citations

Souery, Daniel, Leonardo Zaninotto, Raffaella Calati, et al.. (2011). Phenomenology of psychotic mood disorders: Lifetime and major depressive episode features. Journal of Affective Disorders. 135(1-3). 241–250. 28 indexed citations

Souery, Daniel, Alessandro Serretti, Raffaella Calati, et al.. (2011). Citalopram versus desipramine in treatment resistant depression: Effect of continuation or switching strategies. A randomized open study. The World Journal of Biological Psychiatry. 12(5). 364–375. 36 indexed citations

Souery, Daniel, Leonardo Zaninotto, Raffaella Calati, et al.. (2011). Depression across mood disorders: review and analysis in a clinical sample. Comprehensive Psychiatry. 53(1). 24–38. 33 indexed citations

Souery, Daniel, Alessandro Serretti, Raffaella Calati, et al.. (2011). Switching Antidepressant Class Does Not Improve Response or Remission in Treatment-Resistant Depression. Journal of Clinical Psychopharmacology. 31(4). 512–516. 79 indexed citations

10.

Massat, Isabelle, Neslihan Aygün Kocabaş, Concetta Crisafulli, et al.. (2011). COMT and age at onset in mood disorders: A replication and extension study. Neuroscience Letters. 498(3). 218–221. 28 indexed citations

11.

Kocabaş, Neslihan Aygün, Irina Antonijevic, Carlos Forray, et al.. (2010). Dysbindin gene (DTNBP1) in major depressive disorder (MDD) patients: Lack of association with clinical phenotypes. The World Journal of Biological Psychiatry. 11(8). 985–990. 3 indexed citations

12.

Kocabaş, Neslihan Aygün, Irina Antonijevic, Carlos Forray, et al.. (2010). Brain-derived neurotrophic factor gene polymorphisms. International Clinical Psychopharmacology. 26(1). 1–10. 66 indexed citations

13.

Antonijevic, Irina, Carlos Forray, Siegfried Kasper, et al.. (2010). 5HT1A and 5HT2A receptor genes in treatment response phenotypes in major depressive disorder. International Clinical Psychopharmacology. 25(4). 228–231. 34 indexed citations

14.

Kocabaş, Neslihan Aygün, Siegfried Kasper, Sylvie Linotte, et al.. (2010). The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case–control association study. International Clinical Psychopharmacology. 25(4). 218–227. 46 indexed citations

15.

Mendlewicz, Julien, Isabelle Massat, Sylvie Linotte, et al.. (2010). Identification of clinical factors associated with resistance to antidepressants in bipolar depression: results from an European Multicentre Study. International Clinical Psychopharmacology. 25(5). 297–301. 16 indexed citations

16.

Serretti, Alessandro, Alberto Chiesa, Raffaella Calati, et al.. (2010). A preliminary investigation of the influence of CREB1 gene on treatment resistance in major depression. Journal of Affective Disorders. 128(1-2). 56–63. 39 indexed citations

17.

Serretti, Alessandro, Raffaella Calati, Isabelle Massat, et al.. (2009). Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes are not associated with response and remission in a sample of depressive patients. International Clinical Psychopharmacology. 24(5). 250–256. 58 indexed citations

18.

Linotte, Sylvie, et al.. (2008). Dissociation in Major Depressive Disorder: A Pilot Study. Journal of Trauma & Dissociation. 9(3). 411–421. 20 indexed citations

19.

Oswald, Pierre, Daniel Souery, Isabelle Massat, et al.. (2003). Lack of association between the 5HT2A receptor polymorphism (T102C) and unipolar affective disorder in a multicentric European study. European Neuropsychopharmacology. 13(5). 365–368. 16 indexed citations

20.

Rossion, Bruno, L. Gauthier, Michael J. Tarr, et al.. (2000). The N170 occipito-temporal component is delayed and enhanced to inverted faces but not to inverted objects. Neuroreport. 11(1). 69–72. 612 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact